文献速递睡眠呼吸障碍

减重与持续气道正压通气对阻塞性睡眠呼吸暂停及代谢指标的影响:按颅面表型分层随机临床试验

Effect of Weight Loss and Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Metabolic Profile Stratified by Craniofacial Phenotype: A Randomized Clinical Trial.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01

该随机临床试验纳入194例BMI≥25 kg/m2的中重度阻塞性睡眠呼吸暂停中国肥胖患者,按2:1随机分配至生活方式干预减重组或CPAP组治疗6个月。结果显示减重组超敏C反应蛋白下降更显著、胰岛素敏感性改善且正常血糖调节比例更高,且减重对代谢指标的改善不受颅面结构(上颌下颌体积)分层影响。

要点

  • 减重较CPAP更显著降低中重度OSA肥胖患者hsCRP并改善胰岛素敏感性。
  • 减重对代谢指标的改善不受颅面结构(MMV大小)影响。
  • 减重组达到低hsCRP(<1 mg/L)的患者比例高于CPAP组。

核心结论

  • 在BMI≥25 kg/m2的中重度OSA中国肥胖患者中,减重较CPAP更显著减轻亚临床炎症并改善胰岛素敏感性,且该效应不受颅面结构影响。

研究设计与样本

  • 随机临床试验,194例BMI≥25 kg/m2的中重度OSA患者按2:1随机分配至生活方式干预减重组(128例)或CPAP组(66例),治疗6个月。
  • 评估包括CT测量上颌下颌体积(MMV)、超敏C反应蛋白(hsCRP)和胰岛素敏感性。
  • 减重组按MMV中位数233.2 cm3分为小MMV组(n=64)和大MMV组(n=64)进行亚组分析。

主要发现

  • 减重组hsCRP下降幅度大于CPAP组(中位数[四分位距]:-0.7[-1.4至-0.0] vs -0.3[-0.9至0.4] mg/L;P=0.012)。
  • 减重组达到低hsCRP(<1 mg/L)的患者比例高于CPAP组(21.1% vs 9.1%;P=0.04)。
  • 胰岛素敏感性仅在减重组改善,干预后正常血糖调节患者数为对照的3.1倍(95%CI 1.5-6.6)。
  • 减重组内小MMV与大MMV亚组间hsCRP变化(中位数[四分位距]:-0.7[-1.3至0.1] vs -0.7[-1.5至-0.2] mg/L;P=0.884)和胰岛素敏感性变化(中位数[四分位距]:0.5[-0.2至1.9] vs 0.6[0.1至2.0];P=0.4860)无显著差异。

关键数值与推荐

  • 入组标准:BMI≥25 kg/m2且为中重度OSA。
  • 随机比例:减重组与CPAP组为2:1。
  • MMV分层阈值:中位数233.2 cm3。
  • 低hsCRP定义:<1 mg/L。

临床怎么用

  • 对BMI≥25 kg/m2的中重度OSA肥胖患者,减重干预可作为改善亚临床炎症和胰岛素敏感性的重要策略。
  • 颅面结构(MMV)不宜作为选择减重或CPAP以改善代谢指标的决策依据。

局限性

  • 研究对象为中国肥胖OSA患者,结果外推至其他人群需谨慎。
  • 随访时间为6个月,长期代谢获益未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Craniofacial structure is believed to modulate the effect of weight loss on obstructive sleep apnea (OSA), but whether this affects metabolic profile after weight loss compared with continuous positive airway pressure (CPAP) is unknown among obese Chinese patients with OSA. Objectives: To compare the change in metabolic profile between a lifestyle modification program (LMP), stratified by craniofacial phenotype, and CPAP therapy for 6 months. Methods: We randomly assigned 194 patients with body mass index ⩾ 25 kg/m2 and moderate to severe OSA to participate in the LMP or receive CPAP therapy for 6 months in a 2:1 ratio. Assessments included computed tomography for assessing maxillomandibular volume (MMV), hsCRP (high-sensitivity C-reactive protein), and insulin sensitivity. Measurements and Main Results: Among 128 and 66 subjects in the LMP and CPAP groups, respectively, hsCRP was reduced more in the LMP group than the CPAP group (median [interquartile range], -0.7 [-1.4 to -0.0] vs. -0.3 [-0.9 to 0.4] mg/L; P = 0.012). More patients in the LMP group achieved low hsCRP (<1 mg/L) than the CPAP group (21.1% vs. 9.1%; P = 0.04). Insulin sensitivity improved only in the LMP group, with 3.1 (95% confidence interval, 1.5-6.6) times more patients with normal glucose regulation after intervention. The LMP group was stratified into LMP-small MMV (n = 64) and LMP-large MMV (n = 64) groups according to the median MMV value of 233.2 cm3. There was no significant difference in hsCRP (median [interquartile range], -0.7 [-1.3 to 0.1] vs. -0.7 [-1.5 to -0.2] mg/L; P = 0.884) and insulin sensitivity (median [interquartile range], 0.5 [-0.2 to 1.9] vs. 0.6 [0.1 to 2.0]; P = 0.4860) between the LMP-small MMV and LMP-large MMV groups. Conclusions: Weight reduction alleviated subclinical inflammation and improved insulin sensitivity more than CPAP among obese Chinese patients with moderate to severe OSA, and this effect was not influenced by craniofacial structure. Clinical trial registered with www.clinicaltrials.gov (NCT03287973).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Ng SSS, Tam WWS, Lee RWW, et al. Effect of Weight Loss and Continuous Positive Airway Pressure on Obstructive Sleep Apnea and Metabolic Profile Stratified by Craniofacial Phenotype: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2022. PMID: 34936531. doi:10.1164/rccm.202106-1401OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。